申请人:Hoechst Aktiengesellschaft
公开号:US05856344A1
公开(公告)日:1999-01-05
Benzoylguanidines of the formula I ##STR1## in which R(1) to R(6) have the meanings stated in the claims, are antiarrhythmic pharmaceuticals which have excellent activity and a cardioprotective component and are highly suitable for the prophylaxis of infarcts and the treatment of infarcts, and for the treatment of angina pectoris, in which case they also preventively inhibit or greatly reduce the pathophysiological processes in the development of ischemia-induced damage, especially in the triggering of ischemia-induced cardiac arrhythmias.
式I中的苯甲酰胍类化合物,其中R(1)到R(6)具有声明中所述的含义,是具有优异活性和心脏保护成分的抗心律失常药物,非常适用于预防梗塞和治疗梗塞,并用于治疗心绞痛,在这种情况下,它们还可以预防性地抑制或大大减少缺血引起的损伤的病理生理过程,特别是在缺血引起的心脏心律失常的触发方面。